Medical supplies contracts in Germany

299 open tenders

CountryTenderValueClosesDays left

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Lanreotide, ATC H01CB03, for the period 01.04.2026 - 31.03.2027 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 115409-2026

€11 lot, 1 year

Sat 5 Feb12:00 in Berlin

464days

Conclusion of a non-exclusive discount agreement pursuant to §130a Abs. 8 SGB V for the active substance Dexamethasone (exclusively dosage form IMP), ATC S01BA01, for the period 01.04.2026 - 31.03.2028

DAK-Gesundheit, HamburgTED 115975-2026

€11 lot, 2 years

Sat 5 Feb12:00 in Berlin

464days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for the active substance Galcanezumab, ATC N02CD02, for the period 01.04.2026 – 31.03.2028

DAK-Gesundheit, HamburgTED 114799-2026

€11 lot, 2 years

Sat 5 Feb12:00 in Berlin

464days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Interferon beta-1, ATC L03AB08, for the period 01.04.2026 - 31.03.2028

DAK-Gesundheit, HamburgTED 116153-2026

€11 lot, 2 years

Sat 5 Feb12:00 in Berlin

464days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the Fifth Book of the German Social Code (SGB V) for the active substance Beclometasone (excluding DaFo IHP), ATC R03BA01, for the period 01.05.26–30.04.28

DAK-Gesundheit, HamburgTED 183467-2026

€11 lot, 2 years

Sun 5 Mar12:00 in Berlin

493days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the Fifth Book of the German Social Code (SGB V) for the active substance Trientine (exclusively for pharmaceutical form FTA), ATC A16AX12, for the period 01.05.26–30.04.28

DAK-Gesundheit, HamburgTED 188197-2026

€11 lot, 2 years

Sun 5 Mar12:00 in Berlin

493days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the Fifth Book of the German Social Code (SGB V) for the active substance Sofosbuvir and Velpatasvir, ATC J05AP55, for the period 01.05.26–30.04.28

DAK-Gesundheit, HamburgTED 183201-2026

€11 lot, 2 years

Sun 5 Mar12:00 in Berlin

493days

Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Trientin (exclusively in the form of HKP), ATC A16AX12 for the period 01.05.26-30.04.28

DAK-Gesundheit, HamburgTED 188871-2026

€11 lot, 2 years

Sun 5 Mar12:00 in Berlin

493days

Conclusion of Non-Exclusive Discount Agreements under § 130a Paragraph 8 SGB V (Open-House Model)

AOK - Die Gesundheitskasse in Hessen Postanschrift: Kölner Str. 8, EschbornTED 241137-2026

value not stated1 lot

Sat 1 Apr12:00 in Berlin

520days

Conclusion of Non-Exclusive Discount Agreements under § 130a Paragraph 8 SGB V (Open-House Model)

AOK - Die Gesundheitskasse in Hessen Postanschrift: Kölner Str. 8, EschbornTED 244201-2026

value not stated4 lots

Sat 1 Apr12:00 in Berlin

520days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active substance Dolutegravir, ATC J05AJ03 for the period 01.06.2026 - 31.05.2028

DAK-Gesundheit, HamburgTED 264323-2026

€11 lot, 2 years

Wed 5 Apr12:00 in Berlin

524days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active substance Daridorexant, ATC N05CJ03 for the period 01.06.2026 - 31.05.2028

DAK-Gesundheit, HamburgTED 264220-2026

€11 lot, 2 years

Wed 5 Apr12:00 in Berlin

524days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active substance Tiotropium + Olodaterol, ATC R03AL06 for the period 01.06.2026 - 31.05.2028

DAK-Gesundheit, HamburgTED 264598-2026

€11 lot, 2 years

Wed 5 Apr12:00 in Berlin

524days

Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Roxadustat, ATC B03XA05 for the period 01.06.2026 - 31.05.2028

DAK-Gesundheit, HamburgTED 264872-2026

€11 lot, 2 years

Wed 5 Apr12:00 in Berlin

524days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active substance Trastuzumab (exclusively 600 mg i.e.D.), ATC L01FD01 for the period 01.06.2026 - 31.05.2028

DAK-Gesundheit, HamburgTED 264194-2026

€11 lot, 2 years

Wed 5 Apr12:00 in Berlin

524days

Conclusion of a non-exclusive rebate agreement under § 130a Abs. 8 SGB V for the active substance Betamethasone + Calcipotriol (excluding Dafo Foam), ATC D05AX22 for the period 01.06.2026 - 31.05.2028

DAK-Gesundheit, HamburgTED 262296-2026

€11 lot, 2 years

Wed 5 Apr12:00 in Berlin

524days

Conclusion of Non-Exclusive Discount Agreements Pursuant to § 130a para. 8 of the German Social Code Book V (Open-House Model)

AOK - Die Gesundheitskasse in Hessen Postanschrift Frau Corinna Varelmann ILM-Arzneimittel 64520 Groß-Gerau Land: Deutschland Kontaktstelle(n): z. Hd. Frau Corinna Varelmann E-Mail: [email protected] Telefon: +49 69 6681 6259 711 Internet-Adresse(n):Hauptadresse: http://www.aok.de/hessen/, EschbornTED 335126-2026

value not stated17 lots

Mon 1 May12:00 in Berlin

550days

Conclusion of non-exclusive discount agreements pursuant to § 130a para. 8 SGB V (Open-House Model)

value not stated1 lot

Mon 1 May12:00 in Berlin

550days

Open-House Contracts 2026-2

AOK Bremen/BremerhavenTED 271510-2026

value not stated42 lots

Mon 1 May23:59 in Berlin

550days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for the active substance Erythropoietin (Epoetin alfa and zeta only), ATC B03XA01, for the period 01.07.2026 - 30.06.2028

DAK-Gesundheit, HamburgTED 332949-2026

€11 lot, 2 years

Fri 5 May12:00 in Berlin

554days

SIMAP: This is not an official publication. The data published on www.simap.ch are authoritative. SIMAP data use is subject to its terms.